1. Home
  2. NBIX vs STN Comparison

NBIX vs STN Comparison

Compare NBIX & STN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBIX
  • STN
  • Stock Information
  • Founded
  • NBIX 1992
  • STN 1954
  • Country
  • NBIX United States
  • STN Canada
  • Employees
  • NBIX N/A
  • STN N/A
  • Industry
  • NBIX Biotechnology: Biological Products (No Diagnostic Substances)
  • STN Military/Government/Technical
  • Sector
  • NBIX Health Care
  • STN Consumer Discretionary
  • Exchange
  • NBIX Nasdaq
  • STN Nasdaq
  • Market Cap
  • NBIX 13.2B
  • STN 12.6B
  • IPO Year
  • NBIX 1996
  • STN N/A
  • Fundamental
  • Price
  • NBIX $139.60
  • STN $108.72
  • Analyst Decision
  • NBIX Strong Buy
  • STN
  • Analyst Count
  • NBIX 18
  • STN 0
  • Target Price
  • NBIX $160.94
  • STN N/A
  • AVG Volume (30 Days)
  • NBIX 782.5K
  • STN 199.0K
  • Earning Date
  • NBIX 10-29-2025
  • STN 08-13-2025
  • Dividend Yield
  • NBIX N/A
  • STN 0.42%
  • EPS Growth
  • NBIX 2.97
  • STN 29.73
  • EPS
  • NBIX 3.39
  • STN 2.80
  • Revenue
  • NBIX $2,509,900,000.00
  • STN $4,511,386,797.00
  • Revenue This Year
  • NBIX $20.66
  • STN $12.74
  • Revenue Next Year
  • NBIX $14.64
  • STN $10.34
  • P/E Ratio
  • NBIX $40.91
  • STN $38.86
  • Revenue Growth
  • NBIX 18.42
  • STN 13.47
  • 52 Week Low
  • NBIX $84.23
  • STN $73.18
  • 52 Week High
  • NBIX $154.61
  • STN $113.50
  • Technical
  • Relative Strength Index (RSI)
  • NBIX 68.09
  • STN 50.01
  • Support Level
  • NBIX $133.62
  • STN $108.20
  • Resistance Level
  • NBIX $137.03
  • STN $110.37
  • Average True Range (ATR)
  • NBIX 2.36
  • STN 2.30
  • MACD
  • NBIX 0.83
  • STN 0.15
  • Stochastic Oscillator
  • NBIX 97.44
  • STN 83.13

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

About STN Stantec Inc

Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. It offers services through the following business operating units; Environmental Services, Infrastructure, Water, Buildings, and Energy & Resources. Maximum revenue is derived from its Infrastructure business unit, which is engaged in evaluating, planning, and designing infrastructure solutions for transportation, community development, and urban spaces. The company's reportable segments are the United States, which derives maximum revenue, Canada, and Global. These segments provide consulting in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics services in the area of infrastructure and facilities.

Share on Social Networks: